1 / 4

Copy Number Variation in neurodevelopmental disorders:

David A Collier Professor of Neuropsychiatric Genetics Institute of Psychiatry david.collier@kcl.ac.uk. Copy Number Variation in neurodevelopmental disorders: from genome research to translational medicine. Neurodevelopmental disorders. Impairment of growth and development of the brain or CNS

tracen
Télécharger la présentation

Copy Number Variation in neurodevelopmental disorders:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. David A CollierProfessor of Neuropsychiatric GeneticsInstitute of Psychiatrydavid.collier@kcl.ac.uk Copy Number Variation in neurodevelopmental disorders: from genome research to translational medicine

  2. Neurodevelopmental disorders • Impairment of growth and development of the brain or CNS • Disorder of brain function that affects emotion, learning ability and memory and that unfolds as the individual grows • Autism, intellectual disability, speech and language delay, ADHD, epilepsy, schizophrenia • High unmet need – aetiology poorly understood, limited treatment options.

  3. Identification of pathogenic copy number variants (CNVs)

  4. Genome research is highly translationalBrain and Behaviour Genetic REsource Genome sequencing - UK10K Sequencing 3,000 patients with developmental disorders www.uk10K.org • Clinical genetics/aetiology • Phenotype-genotype analysis • identification of new pathogenic CNVs • Improvements in genetic counselling for known CNVs • Experimental medicine • Identification of novel drug targets • Stratification of patients for intervention/clinical trials • Development of cellular models for disease (iPSC)

More Related